During the past decade, Naval Medical Center Camp Lejeune conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Naval Medical Center Camp Lejeune" #1 sponsor was "Henry M. Jackson Foundation for the Advancement of Military Medicine" with 4 trials, followed by "U.S. Army Medical Research and Development Command" with 3 trials sponsored, "Naval Medical Center Camp Lejeune" with 2 trials sponsored, "Abbott Medical Optics" with 1 trials sponsored and "University of Pittsburgh" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Naval Medical Center Camp Lejeune" #1 collaborator was "Ministry of Defence, United Kingdom" with 1 trials as a collaborator, "Naval Hospital Camp Lejeune" with 1 trials as a collaborator, "Naval Medical Research Center" with 1 trials as a collaborator, "Uniformed Services University of the Health Sciences" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Naval Medical Center Camp Lejeune" are "Anterior Shoulder Dislocation" (1 trials), "Chronic Migraine" (1 trials), "Coronavirus Disease 2019" (1 trials), "Depression Severe" (1 trials) and "Diarrhea" (1 trials). Many other conditions were trialed in "Naval Medical Center Camp Lejeune" in a lesser frequency.

Most popular intervention types in "Naval Medical Center Camp Lejeune" are "Drug" (6 trials), "Other" (4 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Anti-Sars-CoV-2 Convalescent Plasma" (1 trials), "Arthroscopic Bankart repair procedure" (1 trials), "Brief Cognitive Behavioral Therapy (BCBT)" (1 trials) and "Erenumab 140 Mg/mL Subcutaneous Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Naval Medical Center Camp Lejeune" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Naval Medical Center Camp Lejeune". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Naval Medical Center Camp Lejeune, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Naval Medical Center Camp Lejeune, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".